Management and prognosis of pancreatic cancer over a 30-year period. - Wikidata - wikimedia - TriplyDB

Management and prognosis of pancreatic cancer over a 30-year period.

Management and prognosis of pancreatic cancer over a 30-year period.

http://www.wikidata.org/entity/Q37287408

about

The global impact of endoscopic ultrasound (EUS) regarding the survival of a pancreatic adenocarcinoma in a tertiary hospital.Defining research priorities for pancreatic cancer in Australia: results of a consensus development process.Trends in incidence and management of cancer of the ampulla of Vater.Overcoming drug resistance in pancreatic cancer.Pancreatic cancer tumour initiating cells: the molecular regulation and therapeutic values The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis.Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre.Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.Colonic and anal metastases from pancreato-biliary malignancies Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.Focus on an unusual rise in pancreatic cancer incidence in France.Pancreatic cancer: Wait times from presentation to treatment and survival in a population-based study.Locally Advanced or Metastatic Pancreatic Adenocarcinoma: Easily Available Factors of Predictive Prolonged Survival Under Gemcitabine Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.Surgical management in patients with pancreatic cancer: a Queensland perspective.Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer.Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions.Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965–2007

P2860

Q33532201-C27C3A2D-A32D-4FD8-A7FF-EF14E98CCECE Q33794218-36056825-4758-4817-A57C-D98C1139E617 Q34008700-7BA33541-76DF-4617-B86A-1DDB7053CE85 Q35036615-A45B8CEE-CD99-426E-8299-B286CFABFAA4 Q35819328-89043149-70BF-481E-A3DF-55D0A36F3C96 Q36314705-E584538B-C3A5-4D72-9633-71EDC5ADC2A3 Q36540064-32F0CF4D-F36E-4F23-8812-F0B26CA07630 Q36908349-1846FA21-C6B3-43B4-BE4A-0FE8D7A6AC98 Q37040624-CD57F495-351F-4F8D-8636-69C739A58BC9 Q37350310-93178C6E-BBF0-421A-BAFF-6412159BD3F8 Q37392942-EAD11259-8593-4AEB-8C33-18BE42190566 Q37682547-D6CBDCB0-2FC5-4B77-A8EB-1D19F0D200E8 Q39041043-62BCCF74-2ADD-4DE1-81BF-1B99517922A3 Q40163313-130E4096-10E0-4AF5-BA8B-A9AE204F8F6A Q40775344-DC142B8B-377F-4CFF-B6CA-3F5D5BE5BA8A Q41487497-74DC73F3-719A-400E-A77E-145E04366654 Q43627780-06A4D991-F8FB-44F7-8D93-D030F4C9428F Q43881035-DCD9CD66-5CBC-4624-A753-B968C2E09207 Q44256597-D2CB98C5-46F3-4AF1-9FE3-2CE63950615F Q44317521-5C5D7FF3-5BB3-411B-9489-9BAE30536C53 Q45902239-8825BBE7-F572-48A2-8D52-F1C5D8634AFA Q47151308-11C8DDA2-AE29-4278-9793-513B30116FB4 Q53091414-9D75E005-F7C1-4EA7-A66A-D9A13D2ACE48 Q57159990-94907F95-A3D9-45C0-8152-4624216E20EB Q57258071-58BB4776-6E82-4B8E-9D28-3427E726B75D

P2860

Management and prognosis of pancreatic cancer over a 30-year period.

http://www.wikidata.org/entity/Q37287408

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Management and prognosis of pancreatic cancer over a 30-year period.

@en

Management and prognosis of pancreatic cancer over a 30-year period.

@nl

type

label

Management and prognosis of pancreatic cancer over a 30-year period.

@en

Management and prognosis of pancreatic cancer over a 30-year period.

@nl

prefLabel

Management and prognosis of pancreatic cancer over a 30-year period.

@en

Management and prognosis of pancreatic cancer over a 30-year period.

@nl

P1433

Q37287408-83B57D6C-1D92-4BCB-91A1-90A76CA21C32

P1476

Q37287408-F9DE5FD0-1258-47FB-821A-AAA6DD3A6AA4

P2093

Q37287408-119D491C-0FEF-4518-8362-19E6B1F03CD3

Q37287408-8E3179AB-2B7C-49CB-AFD5-D5DDAB9D6D38

Q37287408-AC8BC6AE-36A6-45F7-987C-D79F77820F35

Q37287408-B0C64B77-2B32-41D3-B56B-31FFD9EA1D84

Q37287408-B4FAD8A3-3D55-4F8A-A7C5-9EFAEDA7B8BD

Q37287408-BAC4EA6C-77EF-45D9-B610-5D2439D491A5

Q37287408-CFECA6C0-23C2-4531-B655-7C648ECBB0CB

P2860

Q37287408-0BE8F6BC-CD39-4C22-8C07-8BA88C0240AA

Q37287408-1424412A-219C-4786-A5F4-D4D99ED8B648

Q37287408-49C6D957-90D8-48F2-BEF3-06CCAEE7926A

Q37287408-6836A5EC-CEE4-4E66-995D-E95E78FEC81D

Q37287408-A54CB5C4-F307-412F-A964-45832E8C609D

Q37287408-CEE9FA90-6AAE-4EA0-A755-DCACB2F96ED5

Q37287408-E9176379-0C26-4942-93FA-296F92608CB7

Q37287408-F6E1BF8D-BF8A-4D68-AFA9-3C0204547E4F

P2888

Q37287408-B214DF2B-2164-4963-A5BD-A613B7160BE8

P304

Q37287408-6BC4048E-3D03-45BD-A5CB-70B49E1356C2

P31

Q37287408-7EE8CDE9-F30B-4AAB-A3D0-0AAEE2E00658

P356

Q37287408-DBB752E8-3A01-4B25-8FBB-E380BDB3F648

P407

Q37287408-98316C8A-2E9A-42D9-A7E4-A1A48D9B44A5

P433

Q37287408-A68FB09E-7B25-4BAD-8346-613AE54647CA

P478

Q37287408-C531A182-9F43-43CE-8A6E-995D164C5CC1

P577

Q37287408-B0CDDACD-15A6-42BE-B4D2-2B0CE69B7721

P5875

Q37287408-6965D4D2-4B4A-47A8-9FD5-BBFB2FE7FE70

P698

Q37287408-3137EF80-55E3-4C50-BE59-6B46CC56D1E8

P932

Q37287408-CF4AC4D4-E442-4357-A0F1-661C9F3EE7FB

P356

P1433

British Journal of Cancer

P1476

Management and prognosis of pancreatic cancer over a 30-year period.

@en

P2093

A-M Bouvier

http://www.w3.org/2001/XMLSchema#string

C Lepage

http://www.w3.org/2001/XMLSchema#string

J Faivre

http://www.w3.org/2001/XMLSchema#string

J-L Jouve

http://www.w3.org/2001/XMLSchema#string

M Chauvenet

http://www.w3.org/2001/XMLSchema#string

M David

http://www.w3.org/2001/XMLSchema#string

V Jooste

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.

Incidence and management of malignant digestive endocrine tumours in a well defined French population.

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.

Survival from cancer of the pancreas in England and Wales up to 2001.

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

National failure to operate on early stage pancreatic cancer.

Prognostic factors for survival in pancreatic cancer: a population-based study.

Differences in Survival by Histologic Type of Pancreatic Cancer

P2888

P304

215-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605150

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26332090

http://www.w3.org/2001/XMLSchema#string

P698

19568238

http://www.w3.org/2001/XMLSchema#string

P932

2720200

http://www.w3.org/2001/XMLSchema#string